These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 29345296)

  • 1. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
    Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
    Wietrzyk J; Milczarek M; Kutner A
    Oncol Res; 2007; 16(11):517-25. PubMed ID: 18306931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model.
    Maj E; Filip-Psurska B; Świtalska M; Kutner A; Wietrzyk J
    Int J Mol Sci; 2015 Nov; 16(11):27191-207. PubMed ID: 26580599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent and sequential administration of sunitinib malate and docetaxel in human non-small cell lung cancer cells and xenografts.
    Wang D; Jiang Z; Zhang L
    Med Oncol; 2012 Jun; 29(2):600-6. PubMed ID: 21455800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
    Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
    J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo.
    Song TH; Chen XX; Lee CK; Sze SC; Feng YB; Yang ZJ; Chen HY; Li ST; Zhang LY; Wei G; Shi J; Xu K; Ng TB; Zhu LL; Zhang KY
    Phytomedicine; 2019 Feb; 53():18-27. PubMed ID: 30668397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
    Chiang KC; Sun CC; Chen MH; Huang CY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Juang HH; Takano M; Kittaka A; Chen TC; Yeh CN; Pang JH
    J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):26-34. PubMed ID: 26385607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interaction between sunitinib and docetaxel is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.
    Pan F; Tian J; Zhang X; Zhang Y; Pan Y
    J Cancer Res Clin Oncol; 2011 Sep; 137(9):1397-408. PubMed ID: 21796416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
    Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
    Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of high-dose EGFR tyrosine kinase inhibitor and sequential docetaxel in wild type EGFR non-small cell lung cancer cell nude mouse xenografts.
    Tang N; Zhang Q; Fang S; Han X; Wang Z
    Oncotarget; 2017 Feb; 8(6):9134-9143. PubMed ID: 27852073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma.
    Hui EP; Lui VW; Wong CS; Ma BB; Lau CP; Cheung CS; Ho K; Cheng SH; Ng MH; Chan AT
    Invest New Drugs; 2011 Dec; 29(6):1123-31. PubMed ID: 20467883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
    Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer.
    Li X; Tong LJ; Ding J; Meng LH
    Cancer Lett; 2014 Jan; 342(1):159-66. PubMed ID: 24018642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
    Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
    Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non-small-cell lung cancer xenograft models.
    Coxon A; Ziegler B; Kaufman S; Xu M; Wang H; Weishuhn D; Schmidt J; Sweet H; Starnes C; Saffran D; Polverino A
    Mol Cancer; 2012 Sep; 11():70. PubMed ID: 22992329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroberberine exhibits synergistic effects with sunitinib on NSCLC NCI-H460 cells by repressing MAP kinase pathways and inflammatory mediators.
    Dai B; Ma Y; Wang W; Zhan Y; Zhang D; Liu R; Zhang Y
    J Cell Mol Med; 2017 Oct; 21(10):2573-2585. PubMed ID: 28444871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
    Pelczynska M; Switalska M; Maciejewska M; Jaroszewicz I; Kutner A; Opolski A
    Anticancer Res; 2006; 26(4A):2701-5. PubMed ID: 16886680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedule-dependent cytotoxicity of sunitinib and TRAIL in human non-small cell lung cancer cells with or without EGFR and KRAS mutations.
    Bao YX; Zhao XD; Deng HB; Lu CL; Guo Y; Lu X; Deng LL
    Cell Oncol (Dordr); 2016 Aug; 39(4):343-52. PubMed ID: 27016208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical PK/PD model for combined administration of erlotinib and sunitinib in the treatment of A549 human NSCLC xenograft mice.
    Li JY; Ren YP; Yuan Y; Ji SM; Zhou SP; Wang LJ; Mou ZZ; Li L; Lu W; Zhou TY
    Acta Pharmacol Sin; 2016 Jul; 37(7):930-40. PubMed ID: 27180983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells.
    Wang Q; Acharya N; Liu Z; Zhou X; Cromie M; Zhu J; Gao W
    J Ethnopharmacol; 2018 May; 217():140-151. PubMed ID: 29458146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.